Advisory Board
Beth Rogozinski
Advisory Board Member, miRoncol Health
- Beth Rogozinski is the CEO of Oncoustics, an AI diagnostics company developing non-invasive, low-cost tools for detecting and monitoring liver, kidney, and pancreatic diseases. A serial entrepreneur and product strategist, she has led innovation across digital health, medical software, and biotechnology. As former Chief Product Officer at Pear Therapeutics, Beth guided the development and FDA clearance of ReSET™, the first prescription digital therapeutic. She brings to Mironcol deep expertise in digital medicine, healthcare commercialization, and the strategic translation of technology into clinical impact.
Jiah Pearson-Leary, PhD
Advisory Board Member, miRoncol Health
- Dr. Jiah Pearson-Leary is the CEO of Spire BioAdvisory and a senior biopharma consultant specializing in translating cutting-edge science into commercially viable therapies. With a background in translational neuroscience from the Children’s Hospital of Philadelphia, she has guided strategic development for breakthrough treatments in Alzheimer’s, immunology, and neuromuscular disease. At Mironcol, Dr. Pearson-Leary contributes expertise in corporate strategy, full-cycle drug development, and market insight—bridging scientific innovation with the pathways that bring next-generation diagnostics and therapeutics to patients.
Vinona Bhatia, MD, MPH
Advisory Board Member, miRoncol Health
- Dr. Vinona Bhatia is a physician, healthcare strategist, and investor with over 15 years of experience in oncology, digital health, and startup development. As Principal at Atapir, she is helping redefine patient care through AI-powered, non-contact monitoring technology that delivers continuous, real-time insights without physical burden. Dr. Bhatia has led strategic investments and clinical initiatives across the U.S. and global markets, guiding medical startups in clinical trial design, regulatory strategy, and commercialization. She brings to Mironcol deep expertise in precision oncology, digital innovation, and global health impact.
